INTRODUCTION
Streptococcus pneumoniae is one of the most important human pathogens, causing a spectrum of diseases, including pneumonia, bacteraemia, meningitis, sinusitis and otitis media. Effective management and surveillance of pneumococcal disease is hampered by the difficulty in accurately diagnosing infections caused by S. pneumoniae. Currently available laboratory tests have either too low sensitivity to diagnose pneumococcal disease and/or fail to differentiate between the presence of S. pneumoniae as a colonizer or as an invasive pathogen . PCR assays have improved the ability to detect many pneumonia-causing pathogens, although the application of PCR to diagnose pneumococcal disease has been limited. However, there is emerging evidence that a high pneumococcal load detected in some clinical specimens may be associated with worse patient outcomes, including septic shock and mortality (Waterer & Rello, 2011) .
In the present study, we tested a variety of clinical specimens from adults with community-acquired pneumonia (CAP) using a quantitative pneumococcal real-time PCR assay. We hypothesized that a higher pneumococcal load would be: (i) detected in specimens from patients with positive blood cultures, sputum cultures and urinary antigen test results for pneumococcus; and (ii) associated with increased disease severity.
METHODS
Subjects. From July 1999 to July 2000, 304 adult patients aged ¢18 years admitted to Christchurch Hospital, Christchurch, New Zealand, were enrolled in a study of CAP. Inclusion and exclusion criteria were based on those used in previous studies (British Thoracic Society, 1987; Neill et al., 1996) . Detailed descriptions of the study, including patient demographics and clinical presentations, have been previously published. Important characteristics of the study population included that 29 % of the patients had chronic obstructive pulmonary disease (COPD), 13 % suffered from asthma and 19 % were current smokers Murdoch et al., 2001 Murdoch et al., , 2003 Jennings et al., 2008) .
All patients presented with an acute illness with clinical features of pneumonia and radiographic shadowing in one lobe or at least a lung segment, which was neither pre-existing, nor attributable to a known cause. Patients were only included if pneumonia was the main reason for admission and not a terminal event, and when the affected lung tissue was not due to pneumonia distal to bronchial obstruction, bronchiectasis or previous tuberculosis.
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On: Fri, 18 Jan 2019 23:03:17 until tested. The quality of sputum for culture was assessed in accordance with accepted criteria (Murray & Washington, 1975) and only sputa of acceptable quality were cultured.
Sample DNA extraction and PCR amplification. Between 0.5 and 1 ml of thawed serum, sputum and urine underwent DNA extraction with the Promega DNA extraction kit (Abbott Laboratories) according to the manufacturer's instructions. The extraction was performed on an automated M2000sp platform (Abbott Laboratories).
Qualitative real-time PCR amplification. The real-time duplex PCR included the lytA gene target as well as an in-house inhibitor control (unpublished). The pneumococcal lytA gene sequence was detected using the lytA-CDC forward primer (59-ACGCAATCTAGCAG-ATGAAGCA-39) and reverse primer (59-TCGTGCGTTTTAATTC-CAGCT-39) as previously described and a FAM-labelled lytA-CDC reversed probe (59-6FAM-CTCCCTGTATCAAGCGTTTTCGGCA-BBQ) with a reverse strand modification of the CDC probe used in previous publications (Carvalho et al., 2007) .
Real-time duplex PCR assays were performed in a final volume of 30 ml, containing 10 ml DNA, on the ABI 7500 RT-PCR system (Applied Biosystems) with Abbott optical 96-well reaction plates and adhesive covers. The PCR mixture contained 26 Universal TaqMan Gene Expression Master Mix (Applied Biosystems) with each primer at a concentration of 0.5 mM, and probes were used at a concentration of 0.2 mM. A positive S. pneumoniae extraction and a 'no template' control (molecular grade water) were included in each amplification run. Cycling conditions were as follows: 50 uC for 2 min, 95 uC for 10 min, followed by 45 cycles of 95 uC for 15 s and 60 uC for 1 min. Analysis of qualitative results was performed with ABI 7500 software version 2.0.1. (Lim et al., 2003) .2, (ii) pneumonia severity index (PSI) risk class (Fine et al., 1997) IV or V, (iii) intensive care unit admission, (iv) in-hospital death and (5) hospital stay .5 days. The other variables included in each model were: lytA PCR results (binary variable or grouped as 0, 1-1000, 1001-10 5 and .10 5 c.f.u. ml
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), age (years), gender (binary variable), duration of symptoms prior to admission (days), status as a previous or current smoker (binary variable) and antibiotic use prior to admission (binary variable). For all logistic regression analyses, likelihood ratio tests were used to compare models with and without interaction terms.
RESULTS
Of the 304 enrolled patients, 48 % were female and 52 % were male. At the time of enrolment, blood was drawn for various routine investigations, including microbiological culture. Of the 304 patients, 303 provided serum, 196 provided sputum and 256 provided urine specimens, which were used for PCR testing, and 274 patients had blood cultures taken on admission, which were available for comparison to PCR results from serum. Overall, 173 patients had a complete set of serum, sputum and urine samples available for PCR testing.
Analytical sensitivity of quantification
The lower limit of detection in the PCR was ,10 copies of the lytA gene, which is in agreement with previously published data (Carvalho et al., 2007) . The lowest quantifiable dilution of lytA in clinical specimens was reproducible to the level of 10 2 c.f.u. ml
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Comparison of qualitative PCR targeting the lytA gene with other diagnostic tests Table 1 shows the comparison of qualitative PCR results targeting the lytA gene with other diagnostic tests on the same patients. Statistically significant differences were noted between the performance of the lytA gene-targeting PCR and all other tests under comparison. The PCR detected S. pneumoniae in all but two sputum specimens that were culture-positive, but also detected S. pneumoniae in an additional 51 culture-negative specimens. PCR detected S. pneumoniae in serum from 6 out of the 11 patients with positive blood cultures and in urine from only 4 out of the 69 patients with positive urinary antigen tests.
Quantitative PCR results
For PCR-positive specimens, the S. pneumoniae bacterial loads were higher in sputum specimens Figs 1 and 2 show the bacterial loads in all PCR-positive specimens for two specimen types and for culture-positive and -negative results. It is of note that bacterial loads were statistically significantly higher in culture-positive compared to culture-negative sputum specimens and in serum from patients with positive blood cultures compared to those with negative blood cultures. Positive and negative urine antigen detection tests were compared to bacterial loads using the PCR assay to detect the lytA gene but they did not show any correlation between higher bacterial loads and positive antigen tests in the urine. Only six data points were analysed (data not shown).
PCR results and antibiotic use
Eighty-eight patients had received antibiotics prior to admission, including amoxicillin (12), coamoxyclav (31), macrolides (32) and other antibiotics (13). Detection of S. pneumoniae by PCR in sputum was statistically significantly less common in patients who had been administered antibiotics prior to hospitalization and specimen collection [odds ratio (OR) 0.26; 95 % confidence interval (CI) 0.l3 to 0.52, P,0.0001]. There was no association between prior antibiotic use and PCR positivity in either serum (OR 0.43; 95 %CI 0.15 to 1.33, P50.13) or urine (OR 2.55; 95 % CI 0.50 to 13.00, P50.24) specimens. There were also no statistically significant differences between bacterial loads with or without antibiotic use for each of the three specimen types (data not shown).
Association of PCR results with disease severity
Overall, 71 patients had a CURBage score .2, 146 were PSI risk class IV or V, eight were admitted to the intensive care unit, 11 died in hospital and 160 had a hospital stay greater than 5 days. Table 2 shows the associations between qualitative PCR results and other pneumococcal diagnostic tests (blood culture, sputum culture, urinary antigen) with disease severity after adjusting for age, gender, duration of symptoms, smoking history and prior antibiotic use. The inclusion of an interaction term between sputum pneumococcal PCR and smoking significantly improved the model for severe disease as assessed by PSI risk class assignment. No other interaction terms significantly improved any of the models. Table 3 shows the results for the same models run with quantitative PCR results, showing the association between pneumococcal load and disease severity.
Detection of pneumococcus in serum by PCR was associated with four markers of severe disease; with three markers (CURBage score, PSI risk class and ICU admission) there were increased odds of severe disease with increasing bacterial load. Detection of pneumococcus in urine associated with severe disease was established with the CURBage score only, while detection in sputum was only associated with severe disease when assessed by using the PSI risk class in patients who had never smoked. The inclusion of additional variables for the detection of other viral or bacterial pathogens did not significantly change any of these findings (data not shown). Blood culture Serum bacterial load (cfu ml 
DISCUSSION
A main finding of this study was that detection of pneumococcal DNA in serum was associated with severe disease in adults with CAP and, for some variables, increased bacterial load was associated with increased disease severity. We did not observe an association between bacterial load and disease severity for sputum specimens, except for one group of patients; previous and current smokers, who were more likely to be in one of the higher PSI risk classes if pneumococcal DNA was detected in sputum. There was an association between pneumococcal DNA in urine and disease severity as assessed by the CURBage score, but this was not evident with other markers. The significance of the latter two findings is unclear and may represent chance findings; therefore, these tests need to be replicated in other patient populations.
The findings from serum PCR in this study are consistent with other recent reports. Among Spanish adults with CAP, high pneumococcal loads in blood were associated with increased risk of both septic shock and mortality (Rello et al., 2009) . This study also found that there was a marked increase in mortality above a bacterial load of 10 5 c.f.u. ml
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. The relatively small number of deaths in our study will have limited our ability to demonstrate any associations with mortality. Pneumococcal load in blood has also been associated with the development of systemic inflammatory response syndrome in adults with CAP (Peters et al., 2009) . In children with meningitis and pneumonia, pneumococcal load was also associated with mortality as well as inflammatory markers (Carrol et al., 2007) .
The use of PCR as a diagnostic tool for pneumococcal disease has had mixed results. Qualitative PCR has been useful for detection of pneumococcal DNA in blood specimens, especially from children (Azzari et al., 2011; Marchese et al., 2011) , but detection in respiratory specimens has been difficult to interpret because of the inability to differentiate colonization from infection (Dagan et al., 1998; Murdoch et al., 2003) . The choice of PCR assay can have a noticeable A. M. Werno, T. P. Anderson and D. R. Murdoch effect on results. In a previous study, we used a different assay that targeted the pneumolysin (ply) gene (Murdoch et al., 2003) . This assay has since been shown to have relatively low specificity (Whatmore et al., 2000; Messmer et al., 2004; Suzuki et al., 2005; Carvalho et al., 2007) , especially compared with pneumococcal lytA-based PCR assays (Sheppard et al., 2004; Abdeldaim et al., 2010) , and, thus, the use of ply-based quantitative PCR assays has been questioned with regard to its clinical usefulness (Abdeldaim et al., 2009) . Consequently, the lytA gene was chosen as the target for the quantitative PCR assay in the present study. This gene is thought to be present in most, if not all, pneumococcal serotypes; although, it is acknowledged that occasional non-pneumococcal strains may also harbour the lytA gene (Carvalho et al., 2007; Abdeldaim et al., 2008) .
In the present study, using PCR we detected S. pneumoniae in almost all culture-positive samples and in many culturenegative sputum specimens, presumably reflecting the increased sensitivity of PCR as a method of detection. In contrast, serum specimens from five of the 11 patients with positive blood cultures were PCR-negative and an additional 17 serum specimens from blood culture-negative patients were PCR positive. These results may reflect a combination of increased sensitivity of PCR and the low-level intermittent nature of pneumococcal bacteraemia with occasional sampling errors causing false-negative results. We also detected pneumococcal DNA in relatively few urine specimens. The low rate of lytA gene detection in blood cultures and urine may also indicate a sensitivity issue with the PCR assay, which is inherently difficult to investigate due to the lack of a robust 'gold standard'. Although PCR is generally thought to be less affected than culture by prior antibiotic treatment, we noted that detection of S. pneumoniae by PCR in sputum samples, but not in other specimens, was less common in patients who had been administered antibiotics prior to specimen collection.
Others have reported that plasma and pleural fluid bacterial loads are lower after prior antibiotic use (Muñoz-Almagro et al., 2011) . The application of quantitative PCR enabled the estimation of pneumococcal burden in clinical specimens. In general, our findings were not surprising with pneumococcal loads being considerably higher in sputum specimens than in positive serum or urine specimens. In addition, bacterial loads based on PCR targeting the lytA gene were higher in culture-positive compared to culturenegative sputum specimens and in serum from patients with positive blood cultures compared to those with negative blood cultures.
The limitations of this study are the incompleteness of sputum, serum and urine sets for all patients, and the relatively small number of PCR-positive serum and urine samples. The relatively small number of patients who were admitted to the intensive care unit and the small number of mortalities limited our ability to analyse these variables as markers of disease severity. Another limiting factor of the study was the use of serum instead of whole blood. The latter specimen type has the theoretical advantage of also capturing intracellular organisms but such samples were unavailable to test in our study. In addition, sample deterioration may have occurred through storage resulting in false-negative results. Finally, the lack of nasopharyngeal swabs from the patients prevents us from evaluating the utility of measuring pneumococcal load in this specimen type. Recent data have shown some interesting associations between nasopharyngeal pneumococcal load and the presence of radiologically confirmed pneumonia and viral co-infection in children (Vu et al., 2011) and it would be interesting to assess the association between this and disease severity in adults as well. Reports have demonstrated an association between invasiveness and severity of disease with certain pneumococcal serotypes (Rodríguez et al., 2011) . Serotype or molecular data of the pneumococcal isolates in this study could have provided further information about the association of strains with severity of disease; however, these data were not available. The strength of the present study is the use of specimens from a very well-characterized group of adults with CAP.
This study adds to an increasing body of evidence, suggesting that determination of pneumococcal load has a clinical utility. Higher pneumococcal load in serum and, possibly, urine was associated with increased disease severity in adults with pneumonia. Further work is needed to determine whether measuring pneumococcal load in respiratory specimens from adults will differentiate colonization from coincidental carriage.
